tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CAPR Stock Latest News

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
Press ReleasesCapricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
6h ago
CAPR
Capricor Therapeutics to Present at Upcoming Investor Conferences
PremiumPress Releases
Capricor Therapeutics to Present at Upcoming Investor Conferences
1M ago
CAPR
Capricor Therapeutics, Inc. Is Worried About This – Should You Be Worried Too?
PremiumCompany Announcements
Capricor Therapeutics, Inc. Is Worried About This – Should You Be Worried Too?
1M ago
CAPR
Capricor Therapeutics presents results from HOPE-2 extension study
PremiumThe Fly
Capricor Therapeutics presents results from HOPE-2 extension study
2M ago
CAPR
Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
PremiumPress Releases
Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
2M ago
CAPR
Capricor Therapeutics reports Q4 EPS (2c), consensus (9c)
PremiumThe FlyCapricor Therapeutics reports Q4 EPS (2c), consensus (9c)
2M ago
CAPR
Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
2M ago
CAPR
Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy
PremiumPress Releases
Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy
2M ago
CAPR
Capricor announces company granted in-person Type-B meeting with FDA
PremiumThe Fly
Capricor announces company granted in-person Type-B meeting with FDA
2M ago
CAPR
Is CAPR a Buy, Before Earnings?
PremiumPre-Earnings
Is CAPR a Buy, Before Earnings?
2M ago
CAPR
Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29
PremiumPress Releases
Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29
2M ago
CAPR
Capricor Therapeutics announces manufacturing scale-up of CAP-1002 production
PremiumThe Fly
Capricor Therapeutics announces manufacturing scale-up of CAP-1002 production
2M ago
CAPR
Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2
PremiumPress ReleasesCapricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2
3M ago
CAPR
Capricor Therapeutics, NIH collaborate for trial of StealthX vaccine
PremiumThe Fly
Capricor Therapeutics, NIH collaborate for trial of StealthX vaccine
3M ago
CAPR
Capricor initiated with an Overweight at Cantor Fitzgerald ahead of Phase 3 data
PremiumThe Fly
Capricor initiated with an Overweight at Cantor Fitzgerald ahead of Phase 3 data
4M ago
CAPR
Capricor Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Capricor Therapeutics initiated with an Overweight at Cantor Fitzgerald
4M ago
CAPR
Capricor Therapeutics Announces Continuation of Phase 3 HOPE-3 Trial of CAP-1002 in Duchenne Muscular Dystrophy Based on Completion of Interim Futility Analysis
PremiumPress Releases
Capricor Therapeutics Announces Continuation of Phase 3 HOPE-3 Trial of CAP-1002 in Duchenne Muscular Dystrophy Based on Completion of Interim Futility Analysis
5M ago
CAPR
Capricor Therapeutics announces continuation of Phase 3 HOPE-3 trial
PremiumThe Fly
Capricor Therapeutics announces continuation of Phase 3 HOPE-3 trial
5M ago
CAPR
Capricor Therapeutics reports Q3 EPS (25c), consensus (29c)
PremiumThe Fly
Capricor Therapeutics reports Q3 EPS (25c), consensus (29c)
5M ago
CAPR
Capricor Therapeutics to Present Third Quarter 2023 Financial Results and Recent Corporate Update on November 14
PremiumPress ReleasesCapricor Therapeutics to Present Third Quarter 2023 Financial Results and Recent Corporate Update on November 14
6M ago
CAPR
Is CAPR a Buy, Before Earnings?
PremiumPre-Earnings
Is CAPR a Buy, Before Earnings?
6M ago
CAPR
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments of CAP-1002 Program
PremiumPress Releases
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments of CAP-1002 Program
6M ago
CAPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >